These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 35585518)

  • 1. Adverse effects following COVID-19 vaccination in Iran.
    Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
    BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran.
    Soltani S; Matin BK; Gouya MM; Zahraei SM; Moradi G; Chehri O; Soofi M; Moradinazar M; Shadmani FK; Kalantari M; Khajeha H; Emamian MH; Najafi F
    BMC Public Health; 2023 Jul; 23(1):1415. PubMed ID: 37488541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system.
    Enayatrad M; Mahdavi S; Aliyari R; Sahab-Negah S; Nili S; Fereidouni M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Sheibani H; Abbaszadeh M; Jafari R; Valikhani M; Binesh E; Vahedi H; Chaman R; Sharifi H; Emamian MH
    BMC Infect Dis; 2023 Mar; 23(1):150. PubMed ID: 36899326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects of Sputnik V, Oxford-AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran.
    Oghazian S; Tavanaei Tamanaei T; Haghighi R; Faregh M; Oghazian MB
    Int Immunopharmacol; 2023 Apr; 117():109784. PubMed ID: 36812676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term Side Effects of COVID-19 Vaccines (Astrazeneca, Sputnik-V, and Sinopharm) in Health Care Workers: A Cross-Sectional Study in Iran.
    Azimi-Nezhad M; Gholami A; Taghiabadi E; Ghodsi H
    Med J Islam Repub Iran; 2022; 36():159. PubMed ID: 36721491
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population.
    Moradi Hasan-Abad A; Arbabi M; Gilasi H; Motedayyen H
    Int J Immunopathol Pharmacol; 2024; 38():3946320241239202. PubMed ID: 38494849
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential Adverse Effects of COVID-19 Vaccines on Iranian Healthcare Workers: Comparison of Four Available Vaccines in Tehran: A Retrospective Cross-sectional Study.
    Abdollahi A; Naseh I; Kalroozi F; Kazemi-Galougahi MH; Nezamzadeh M; Qorbanzadeh A; Ameri R; Taghavi H; Zoshk MY
    Oman Med J; 2023 Mar; 38(2):e486. PubMed ID: 37168286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events and SARS-CoV-2 antibody responses after immunization with Sputnik V, ChAdOx1-S, and BBIBP-CorV vaccines in people with HIV.
    Mauas R; Urueña A; Cecchini D; Strada ML; Arietti S; Cassetti I; Nogueira NF; Salazar AS; Rodriguez VJ; Jones DL; Alcaide ML
    AIDS; 2023 May; 37(6):941-946. PubMed ID: 36728228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
    Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.
    Abdel-Qader DH; Abdel-Qader H; Silverthorne J; Kongkaew C; Al Meslamani AZ; Hayajneh W; Ata OMA; Shnaigat W; AbuRuz S; Al Nsour M; Alhariri A; Shnewer K; Da'ssan M; Obeidat NM; Nusair KE; Jalamdeh MS; Hawari F; Khader K; Hakim T; Hammad FA; Al Qudah M; Asad M
    Clin Drug Investig; 2022 Oct; 42(10):813-827. PubMed ID: 35999428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers in Shoushtar, Iran.
    Nabizadeh E; Honarmandpour F; Mashhadizade R; Honarmandpour A
    Clin Pathol; 2023; 16():2632010X231166798. PubMed ID: 37155553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines.
    Adjobimey T; Meyer J; Sollberg L; Bawolt M; Berens C; Kovačević P; Trudić A; Parcina M; Hoerauf A
    Front Immunol; 2022; 13():917905. PubMed ID: 35799790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol: cohort event monitoring for safety signal detection after vaccination with COVID-19 vaccines in Iran.
    Aliyari R; Mahdavi S; Enayatrad M; Sahab-Negah S; Nili S; Fereidooni M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Amini Moridani M; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Sharifi H; Emamian MH
    BMC Public Health; 2022 Jun; 22(1):1153. PubMed ID: 35681132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term side effects of COVID-19 vaccines among healthcare workers: a multicenter study in Iran.
    Mirnia K; Haji Esmaeil Memar E; Kamran N; Yeganedoost S; Nickhah Klashami Z; Mamishi S; Mahmoudi S
    Sci Rep; 2024 Feb; 14(1):4086. PubMed ID: 38374372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
    Pourakbari B; Mirbeyk M; Mahmoudi S; Hosseinpour Sadeghi RH; Rezaei N; Ghasemi R; Esfandiari F; Mamishi S
    J Med Virol; 2022 Dec; 94(12):5669-5677. PubMed ID: 35883215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of COVID-19 vaccines.
    Al Khames Aga QA; Alkhaffaf WH; Hatem TH; Nassir KF; Batineh Y; Dahham AT; Shaban D; Al Khames Aga LA; Agha MYR; Traqchi M
    J Med Virol; 2021 Dec; 93(12):6588-6594. PubMed ID: 34270094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study.
    Stoma I; Korsak K; Voropaev E; Osipkina O; Kovalev A
    Heliyon; 2023 Nov; 9(11):e21877. PubMed ID: 38027828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.
    Sharif N; Opu RR; Saha T; Khan A; Aljohani A; Alsuwat MA; García CO; Vázquez AA; Alzahrani KJ; Miramontes-González JP; Dey SK
    Sci Rep; 2024 Oct; 14(1):23794. PubMed ID: 39394252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
    Jeewandara C; Aberathna IS; Danasekara S; Gomes L; Fernando S; Guruge D; Ranasinghe T; Gunasekera B; Kamaladasa A; Kuruppu H; Somathilake G; Jayamali J; Jayathilaka D; Wijayatilake HDK; Pushpakumara PD; Harvie M; Nimasha T; de Silva SDG; Wijayamuni R; Schimanski L; Rijal P; Tan J; Townsend A; Ogg GS; Malavige GN
    Immunology; 2022 Oct; 167(2):263-274. PubMed ID: 35751563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.